1614P PSA responses and PSMA scan changes after immunotherapy for biochemically recurrent prostate cancer (BCR) without androgen deprivation therapy (ADT)Ravi A. Madan, Fatima Karzai, Philip M. Arlen et al.|Annals of Oncology|2024Cited by 2
2393P Prospective monitoring of prostate specific membrane antigen (PSMA) in biochemically recurrent prostate cancer (BCR): Preliminary data from 1 Year follow-upRavi A. Madan, Peter Choyke, Melissa L. Abel et al.|Annals of Oncology|2025Cited by 0